{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-26-000026","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.339394+00:00","generated_at":"2026-05-15T01:46:02.227313+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teladoc Health Q1 2026 Revenue Falls 2% to $613.8M, Net Loss Narrows to $63.8M","bullets":["First Quarter 2026 revenue of $613.8 million, down 2% year-over-year","Net loss improved to $63.8 million ($0.36 per share) from $93.0 million ($0.53 per share) in prior year","Adjusted EBITDA was $58.2 million, essentially flat year-over-year","Integrated Care segment revenue up 2% to $395.4 million; BetterHelp down 9% to $218.4 million","Company reaffirmed full-year 2026 outlook with revenue range $2.481B-$2.576B and adjusted EBITDA $267M-$306M"],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-26-000026","json":"https://secwatch.observer/filing/0001477449-26-000026.json","markdown":"https://secwatch.observer/filing/0001477449-26-000026.md","text":"https://secwatch.observer/filing/0001477449-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744926000026/0001477449-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744926000026/tdoc-20260429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T01:46:02.227313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a85a6d3e8757e22f7b9f2ce81f8a283b9e50e9bb","claim":"Teladoc Health, Inc. reported the three months ended March 31, 2026 (\"First Quarter 2026\") results: revenue $613.8 million, net income $63.8 million, or $0.36 per share, EPS $0.36 per share. Guidance reaffirmed.","evidence_excerpt":"First Quarter 2026 revenue of $613.8 million, down 2% year-over-year • First Quarter 2026 net loss of $63.8 million, or $0.36 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744926000026/0001477449-26-000026-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026 (\"First Quarter 2026\")"},{"label":"Revenue","value":"$613.8 million"},{"label":"Net income","value":"$63.8 million, or $0.36 per share"},{"label":"EPS","value":"$0.36 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}